Document is current
Any future updates will be listed below
-
Authors
Hiemstra, Andriёtte M. http://orcid.org/0000-0002-6331-9858
MacDonald, Candice E.
van Rensburg, Ilana C.
Stanley, Kim
Maasdorp, Elizna
Mc Anda, Shirley
Tönsing, Susanne
Shaw, Jane Alexandra
Tromp, Gerard
van der Spuy, Gian D.
Urdahl, Kevin B.
Lewinsohn, David M.
Kuivaniemi, Helena
Du Plessis, Nelita
Malherbe, Stephanus T.
Walzl, Gerhard
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (75N93019C0070)
South African Medical Research Council (SHIP-SATBBI)
SANRF (86535)
European and Developing Countries Clinical Trials Partnership (TMA2016CDF1576)
Bill and Melinda Gates Foundation (NuMeRi Node for Infection Imaging)
- License Information
-
More Information
Article History
Received: 14 March 2022
Accepted: 4 April 2022
First Online: 15 April 2022
Declarations
:
: This research study is being performed in accordance with the Declaration of Helsinki and it was approved by the Health Research Ethics Committee of Stellenbosch University (Ref No. REC-130408-012) with a Federal Wide Assurance No. 00001372; IRB 0005240; Study No N19/10/150. The main site of Cascade IMPAc-TB, Seattle Children’s Research Institute, received IRB approval for the study (STUDY00002411) on Nov 3, 2020. Written informed consent is obtained from all study participants before they are enrolled in the study. No prisoners or children are recruited into the study.
: Not applicable.
: The authors declare that they have no competing interests.
